| Literature DB >> 34207073 |
Ana Catarina Sousa1,2, Lígia O Martins3, M Paula Robalo1,2.
Abstract
Laccases are multicopper oxidases that have shown a great potential in various biotechnological and green chemistry processes mainly due to their high relative non-specific oxidation of phenols, arylamines and some inorganic metals, and their high redox potentials that can span from 500 to 800 mV vs. SHE. Other advantages of laccases include the use of readily available oxygen as a second substrate, the formation of water as a side-product and no requirement for cofactors. Importantly, addition of low-molecular-weight redox mediators that act as electron shuttles, promoting the oxidation of complex bulky substrates and/or of higher redox potential than the enzymes themselves, can further expand their substrate scope, in the so-called laccase-mediated systems (LMS). Laccase bioprocesses can be designed for efficiency at both acidic and basic conditions since it is known that fungal and bacterial laccases exhibit distinct optimal pH values for the similar phenolic and aromatic amines. This review covers studies on the synthesis of five- and six-membered ring heterocyclic cores, such as benzimidazoles, benzofurans, benzothiazoles, quinazoline and quinazolinone, phenazine, phenoxazine, phenoxazinone and phenothiazine derivatives. The enzymes used and the reaction protocols are briefly outlined, and the mechanistic pathways described.Entities:
Keywords: biocatalysis; bioprocesses; cross-coupling reactions; green methods; heterocycles; oxidoreductases; sustainability
Mesh:
Substances:
Year: 2021 PMID: 34207073 PMCID: PMC8234338 DOI: 10.3390/molecules26123719
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) Representation of the three-dimensional structure of CotA laccase with the cupredoxin domains coloured differently (residues 1–173, domain1: green; residues 182–340, domain2: blue; residues 369–501, domain 3: violet). The four copper atoms are shown as orange spheres. (B) The mononuclear T1 centre is on the right and the trinuclear centre is on the left. Pictures drawn with the use of PyMOL software and supported by the deposited structure in Protein Database PDB1w6l.
Figure 2Overlap of the active site of the fungal TvL and bacterial CotA laccases with detail on the Asp206/Thr260. Pictures drawn with the use of PyMOL software and supported PDB1w6l and 1KYA. It is believed that carboxylate residues are crucial to oxidise substrates containing phenolic or aromatic amine functional groups aiding in the deprotonation of substrates.
Scheme 1Schematic representation of (A) the laccase-mediator redox cycle; (B) of the mediator–substrate oxidation via the (i) HAT route, (ii) the electron transfer (ET) route and (iii) the ionic oxidation route. Adapted from [20].
Synthetic pathways for nitrogen- and oxygen-based heterocyclic compounds mediated by laccases at optimized reaction conditions.
| Product | Enzyme | Laccase | Commercial | Reaction Conditions | Ref. |
|---|---|---|---|---|---|
| Five-membered rings | |||||
| Benzofuran | TvL |
| --1 | Acetate buffer (0.2 M), pH 4.37, r.t., 3–7 h, (51–99%) | [ |
| AbL |
| --1 | Phosphate buffer (0.2 M), pH 6.0, r.t., 20–49 h, (88–99%) | [ | |
| TvL |
| Fluka, Buchs | Acetate buffer, pH 4.38, r.t., 5h, 67% | [ | |
| AbL |
| Fluka, Buchs | Phosphate buffer (0.2 M), pH 5.96, r.t., 18–24 h, (70–97%) | [ | |
| AbL |
| --1 | Phosphate buffer (0.2 M), pH 6.0, r.t., 17–24 h, (55–98%) | [ | |
| MtL |
| Suberase®, Novozymes | Phosphate buffer (0.1 M), pH 7.15, r.t., 24 h, (37–98%) | [ | |
| PcL |
| --2 | O2, phosphate/citrate buffers (0.1 M), pH 7.0, HBT, r.t., 12 h, (39–65%) | [ | |
| 2-arylbenzimidazoles | -- | -- | Novoprime Base 268, | Acetate buffer (0.1 M): CH3CN (50:50), pH 4.0, r.t., 2–24 h, (56–88%) | [ |
| AbL |
| Fluka | Phosphate buffer (0.2 M) or buffer: methanol (5:2), pH 6.0, r.t., 3–18 h, (50–99%) | [ | |
| TvL |
| Sigma-Aldrich | TvL: TEMPO immobilized on magnetic iron (II,III) oxide nanoparticles heterogeneous | [ | |
| Benzothiazole | -- | -- | Novoprime Base 268, | Acetate buffer (0.1 M): CH3CN (50:50), pH 4.0, 25 °C, 24 h, (48–88%) | [ |
| TvL |
| Sigma-Aldrich | TvL: DDQ (10% mol) catalytic system, phosphate buffer (0.1 M):CH3CN (4%), pH 5.0, 45 °C, 24h, (65–98%) | [ | |
| AbL |
| ASA Spezialenzyme | Phosphate buffer (0.2 M): ethanol (10%), pH 6.0, r.t., 12–28 h, (78–97%) | [ | |
| Six-membered rings | |||||
| Quinazoline and quinazolinone | TvL |
| Sigma-Aldrich | O2 or air, TvL: DDQ catalytic system, phosphate buffer (0.1 M): CH3CN (4%), pH 4.5, 45 °C, 24 h, (80–95%) | [ |
| TvL |
| Sigma-Aldrich | O2 or air, TvL: DBTC or TvL/TEMPO catalytic systems, phosphate buffer (0.1 M): CH3CN (4%), pH 4.5, 45 °C, 20–24 h, (40–96%) | [ | |
| Phenazines | MtL |
| --1 | Britton–Robinson buffer (0.1 M), pH 5.0, 60 °C, 1h | [ |
| CotA- |
| --2 | Phosphate buffer (0.1 M): ethanol (10%), pH 6–7, r.t., 2–24 h, (30–96%) | [ | |
| PoL |
| --2 | Free PoL and immobilised on porous Purolite® carriers, tartrate buffer (40 mM), pH 5.5, 28 °C, 48h | [ | |
| LAC |
| --2 | Air, tartrate buffer (0.1 M), pH 4.0–4.5, 28 °C, 72 h, (19–27%) | [ | |
| Phenoxazines and phenoxazinones | TvL |
| --2 | Free and immobilized TvL on polyacrylamide gel, phosphate buffer (0.1 M), pH 5.0, 25 °C, 1 h, (38–74%) | [ |
| TvL |
| --2 | Phosphate buffer (0.066 M): methanol (2%), pH 5.0, 20 °C, 0.5–23 h, (24–72%) | [ | |
| TvL |
| Oxyzym LA, | Phosphate buffer (0.1 M), pH 6–7, 25 °C, 24 h, (75–90%) | [ | |
| TvL |
| Sigma-Aldrich | Acetate buffer (0.2 M): methanol (5%), pH 6.0, 25 °C, 16 h | [ | |
| TvL |
| Oxyzym LA, | Acetate buffer (0.2 M): methanol (5%), pH 4–6, 25 °C, 24h, (40–93%) | [ | |
| CuL |
| --2 | Tartrate buffer (0.1 M), pH 5, 25 °C, 24 h | [ | |
| CotA- |
| --2 | Phosphate buffer (0.1M): ethanol (10%), pH 6–7, r.t., 2–24 h, (59–97%) | [ | |
| Phenothiazine | TvL |
| Novo Nordisk | Acetate buffer (0.1 M): methanol (15%), pH 5.0, r.t., 6 h, (24–61%) | [ |
| Not mentioned | Sigma-Aldrich | Phosphate buffer: CH3CN (3:1), pH 6.5, 12 h, (83–95%) | [ | ||
1 Not mentioned; 2 Not commercial. DDQ—2,3-dichloro-5,6-dicyano-1,4-benzoquinone; DBTC—3,5-di-tert-butylcathecol.
Figure 3Aromatic scaffolds obtained from oxidation of structurally different aromatic amines using CotA-laccase.
Scheme 2(A) Laccase initiated domino reactions with catechols and 1,3-dicarbonyl compounds [78,79]; (B) Mechanistic proposal for the reaction [78].
Scheme 3Synthesis of the C–O and C–C coupled products assisted by laccases. (A) Synthesis of the 5,6-dihydroxylated benzo[b]furans, C–C coupled products and coumestans [81,82]; (B) Synthesis of 6,7-dihydoxy-2,2-dimethyl-1,3,9-trioxa-fluorene-4-one using catechol and Meldrum’s acid [83].
Scheme 4Laccase-catalysed reaction of o-phenylenediamines with aromatic aldehydes to yield 2-aryl-1H-benzimidazoles [10,72].
Scheme 5(A) Synthesis of benzimidazoles by heterogeneous laccase-catalysed aerobic oxidation of salicyl alcohol; (B) Plausible mechanism for laccase/TEMPO catalysed aerobic oxidation of salicyl alcohol (a) followed by an oxidative cyclization reaction and further biocatalytic aerobic dehydrogenation of intermediate (b) to produce 2-hydroxybenzimidazole (c).
Scheme 6Reaction between 2-aminothiophenol and aldehydes to afford 2-arylbenzothiazoles using (A) Novoprime base 268 laccase [10] and (B) a laccase (T. versicolor)/DDQ catalytic system [85].
Scheme 7Laccase-catalysed reaction between catechol and 2,3-dihydro-2-thioxopyrimidin -4(1H)-ones [86].
Scheme 8(A) Aerobic oxidative synthesis of 2-arylquinazoline and (B) quinazolin-4(3H)-ones catalysed by laccase (T. versicolor)/co-catalyst LMS [85,87].
Scheme 9(A) Synthesis of 2,3-diaminophenazine and (B) 2,7-diaminophenazine-1,6-disulfonic acid by laccase-catalysed aerobic dimerization [72,88].
Scheme 10Synthesis of phenazine derivatives by oxidative homocoupling reactions of aromatic amines mediated by CotA-laccase [65,66,67].
Scheme 11Proposed pathways involved in the formation of symmetric and asymmetric phenazines from substituted aromatic amines by CotA-laccase (adapted from [65,67]).
Scheme 12Synthesis of phenazines as a result of a laccase-mediated (A) homocoupling reaction and (B) heterocoupling reactions of 2-amino-3-methoxybenzoic acid [89,90].
Scheme 13(A) Oxidation of 3-hydroxyanthranilic acid (3-HAA) and 4-methyl-3-hydroxyanthranilic acid (4-M-3-HAA) to cinnabarinic acid and actinocin, respectively, using T. versicolor laccase [91,108]; (B) synthesis of 2-aminophenoxazin-3-one derivatives [92] and (C) oxidation of sulphonamide derivatives of 3-hydroxyorthanilic acid and 3-amino-2-hydroxybenzenesulfonic acid by T. versicolor and C. unicolor laccases into symmetrically and non-symmetrically substituted phenoxazinones [94,95,96].
Scheme 14Synthesis of phenoxazinone-based products by oxidative homocoupling reactions of o-aminophenols mediated by CotA laccase [65,67].
Scheme 15Proposed pathways involved in the formation of phenoxazinones from substituted aminophenols by CotA-laccase (adapted from [65,67]).
Scheme 16(A) Laccase-catalysed coupling reactions of 1,2-ethanedithiol or 2-aminothiophenol with 1,4-quinones; (B) Proposed reaction mechanism for the laccase-facilitated synthesis of phenothiazine derivatives [97]; (C) Laccase-catalysed reactions between quinones and substituted 4-amino-4H-1,2,4-triazolo-3-thiols [98].